The device rotates 360 degrees, also scanning vertically. It first snaps hundreds of thousands of measurements, crafting a ...

Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its ...